• Home
  • About Us
  • Blog

Pulmonary Hypertension RN

  • What is Pulmonary Hypertension?
    • What is Pulmonary Hypertension?
    • Pulmonary Hypertension Symptoms
    • Types of Pulmonary Hypertension
    • Causes of Pulmonary Hypertension
    • PH vs. PAH
    • Diastolic Heart Failure vs. PAH
    • WHO Group 3 Pulmonary Hypertension, IPF & COPD
    • Pulmonary Veno-Occlusive Disease
    • Hereditary Hemorrhagic Telangiectasia (HHT)
      • Hereditary Hemorrhagic Telangiectasia (HHT) Treatment
    • Functional Classification of Pulmonary Hypertension
    • Congenital Heart Disease
      • Eisenmenger’s Syndrome
      • Update on Management of PAH-CHD
      • Congenital Heart Disease & Sleep Apnea
      • Complex Congenital Heart Disease
      • Atrial Septal Defect and Pulmonary Arterial Hypertension
    • Pediatric Pulmonary Arterial Hypertension
    • Sickle Cell and Pulmonary Hypertension
    • Stimulant Associated Pulmonary Arterial Hypertension
    • Porto-Pulmonary Syndrome
    • Research, Life Expectancy & Prognosis for PH
  • Diagnosing & Monitoring PAH
    • Pulmonary Arterial Hypertension Diagnosis
    • How Am I Doing? Assessing Your PAH.
    • Blood Tests
    • Cardiopulmonary Exercise Test (CPET)
    • CT (Computed Tomography) Scan
    • Echocardiogram: An Overview
    • Echocardiogram: A Detailed Look
    • Pulmonary Function Tests (PFTs)
    • Right Heart Catheterization
    • Six Minute Walk
    • Ventilation Perfusion Scan (VQ Scan)
    • CTEPH
      • CTEPH: WHO Group 4 Pulmonary Hypertension
      • PTE (Pulmonary Thromboendarterectomy) Surgery
      • Adempas used to Treat PAH and CTEPH
  • PAH Treatment
    • Pulmonary Hypertension Centers
    • Pulmonary Hypertension Treatments
    • Continuously Infused Therapies Used to Treat PH
    • Prostanoids for Treatment of PH
    • Adcirca and Revatio Used to Treat Pulmonary Arterial Hypertension (PAH)
    • Adempas used to Treat PAH and CTEPH
    • Tracleer, Letairis, and Opsumit Treatments
    • Oxygen Therapy for Pulmonary Hypertension
    • Salt and Water Restrictions
    • Exercise & PAH
    • Diuretics
    • Blood Thinners
    • Getting the Most Out of PAH Therapy
      • Letairis
      • Opsumit
      • Sildenafil (Revatio)
  • Research
  • FAQ’s
    • Implanted Remodulin Pump, Right Heart Catheterization, PAH & Pregnancy
    • Oral Treatments, Care Centers & Hole in Heart
    • FAQ’s: Altitude, Cold & Allergy Medications
    • FAQ’s: Psoriasis, Idiopathic PAH, Contraceptives & PAH
    • FAQ’s: Causes of Pulmonary Hypertension, Symptom Frequency & Care Centers
    • FAQ: PAH Experts, Pregnancy, Mild PAH & Vacationing
    • FAQ’s: CTEPH, Blood Clots, Corrective Surgery & PAH Care Centers
    • FAQ’s: VQ Scans & PAH Curable?
    • FAQ’s: Mild Pulmonary Hypertension?
    • FAQ’s: Boating, Swimming & Eating with PAH
    • FAQ’s: Borderline Pulmonary Hypertension, Hand Swelling, Children with PAH, Costs

PH Centers of Excellence

November 20, 2013 By Dr. Jeremy Feldman

A large majority of the comments/questions we receive from our readers are requests for recommendations for a PAH expert close to home.  This is a very important question that is very difficult to answer. Pulmonary arterial hypertension is a rare disease, community physicians may not know of any PH specialists in their area.PH centers of excellence Currently there is not a certification for Pulmonary Hypertension Centers of Excellence. Without an official certification process anyone can claim that they are PH specialists.

The PHA (Pulmonary Hypertension Association) has a list of physicians that have registered as PH providers at www.phassociation.org/Patients/FindADoctor.  These physicians answer a few basic questions such as how many pulmonary hypertension patients do they treat and how many patients do they have on each therapy.  This information is only updated at the discretion of the physician and the profiles can become out of date very quickly.  At the present time there isn’t a threshold to be listed, a physician may have one PH patient or one thousand PH patients and they will both appear on the list in the same way.

Pulmonary hypertension is a progressive disease that can be fatal without treatment.  There are now several therapies to treat PH so it is very important to get to a PH specialist as quickly as possible upon symptom onset.  For this reason the PHA has announced a new program to accredit PH Care Centers.  They are currently putting together a team of healthcare professionals experienced in caring for PH patients to review applications from centers wanting to be accredited and to conduct on site visits to the centers.  The application process is expected to open in early 2014.  The PHA expects the process of accrediting current PH Care Centers to take three to four years.

If you are currently looking for a PH specialist the current PHA list of physicians is a great place to start.  Google the physicians you are interested in seeing or look up their practice’s website.  If you can’t find information about them on the web call their office and ask a few basic questions.  PH specialists should be cardiologist or pulmonologist with specific training in PAH.  The physician should have experience with oral, inhaled, and continuously infused therapies.  The practice should have PH coordinators dedicated to caring for PH patients.  PH support groups and research trials should be available.  The PHA will start adding the PH Care Centers that have been accredited as they move forward.  Check back for more information on this topic as it becomes available.

Filed Under: Blog, Home Page, Living with PAH, PH Doctors & Centers, Pulmonary Hypertension Diagnosis, Pulmonary Hypertension Prognosis, Pulmonary Hypertension Treatments, Uncategorized

PAH Life Expectancy

PAH Research

Research, Life Expectancy & Prognosis for PH

Major Developments in Pulmonary Hypertension Affecting Prognosis 1.     Approval of

Where to Get Treatment?

CCCs for PAH

Pulmonary Hypertension Centers

Where to get treatment for pulmonary hypertension? Pulmonary arterial hypertension is a

Popular Posts

PAH Patient Assistance in 2018

By Dr. Jeremy Feldman

2017 is now behind us.  As 2018 begins there are some major changes in the landscape for patient assistance.  For many

update

May 2019 Update on Clinical Trials in PAH

By Dr. Jeremy Feldman

Sustained Release Beraprost This study looked at the addition of sustained release beraprost or placebo added to

good news in pah

 

Disclaimer

Recent Blog Posts

  • In Memoriam:  Greg Ahearn, MD June 16, 2024
  • Sotatercept (Winrevair) Approved! June 1, 2024
  • Disappointing News for Rodatristat Ethyl October 11, 2023

Categories

Archives